Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Essigen Combination 1 X Capsule ; Drops ; Liquid ; Powder ; Tablet is a Health Canada–registered human drug (DIN 02233131) held by Seroyal International Inc., containing Elm Bark. Health Canada lists its status as Cancelled Post Market (status date 06 Jul 2009). Nexara Health has matched 1 registration of Elm Bark across 1 other regulated market.

Health Canada registration

DIN02233131
Brand nameEssigen Combination
Active ingredientElm Bark
Strength1 X
Dosage formCapsule ; Drops ; Liquid ; Powder ; Tablet
RouteOral
CompanySeroyal International Inc.
StatusCancelled Post Market — 06 Jul 2009
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Elm Bark registered in other markets

1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
TaiwanElm Bark PowderEli. Lilly & Co.(粉)已註銷TFDA

See every manufacturer of Elm Bark worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Essigen Combination (DIN 02233131) marketed in Canada?

No. Health Canada lists DIN 02233131 as Cancelled Post Market as of 06 Jul 2009.

Who holds the Canadian licence for this product?

Seroyal International Inc. is the company of record in the Health Canada Drug Product Database.

Is Elm Bark registered outside Canada?

Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02233131, status date 2009-07-06; national medicine registries: TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02233131, status date 2009-07-06; national medicine registries: TFDA.

Health Canada Drug Product Database (DPD), DIN 02233131, status date 2009-07-06; national medicine registries: TFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.